GSK chief rules out AstraZeneca buyout

GSK ($GSK) chief Andrew Witty (photo) quickly dismissed any idle speculation that he might be interested in buying the struggling British rival AstraZeneca ($AZN). A buyout, he said, would be "very di…
Read the full story: News